Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Nomura, Kyoichi"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-20 z 20
    Tytuł:
    Churg-Strauss syndrome manifesting as perforation of the small intestine: report of a case.
    Autorzy:
    Murakami S; Department of Surgery, Saitama Medical School, Morohonngo 38, Moroyama-machi, Saitama 350-0945, Japan.
    Misumi M
    Sakata H
    Hirayama R
    Kubojima Y
    Nomura K
    Ban S
    Pokaż więcej
    Źródło:
    Surgery today [Surg Today] 2004; Vol. 34 (9), pp. 788-92.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Churg-Strauss Syndrome/*complications
    Intestinal Perforation/*etiology
    Intestinal Perforation/*surgery
    Intestine, Small/*pathology
    Intestine, Small/*surgery
    Abdominal Pain/etiology ; Adrenal Cortex Hormones/therapeutic use ; Churg-Strauss Syndrome/drug therapy ; Female ; Humans ; Intestinal Perforation/complications ; Middle Aged ; Peritonitis/etiology ; Risk Factors
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Distal lipid storage myopathy due to PNPLA2 mutation.
    Autorzy:
    Ohkuma A; Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8502, Japan.
    Nonaka I
    Malicdan MC
    Noguchi S
    Ohji S
    Nomura K
    Sugie H
    Hayashi YK
    Nishino I
    Pokaż więcej
    Źródło:
    Neuromuscular disorders : NMD [Neuromuscul Disord] 2008 Aug; Vol. 18 (8), pp. 671-4. Date of Electronic Publication: 2008 Jul 26.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Distal Myopathies/*genetics
    Lipase/*genetics
    Adult ; Atrophy ; Cardiomyopathy, Dilated/etiology ; Cardiomyopathy, Dilated/genetics ; Cardiomyopathy, Dilated/pathology ; Distal Myopathies/pathology ; Hand/pathology ; Humans ; Leg/pathology ; Lipid Metabolism/genetics ; Lipid Metabolism/physiology ; Male ; Mountaineering ; Muscle Fibers, Skeletal/pathology ; Muscle Weakness/etiology ; Muscle, Skeletal/pathology ; Mutation/genetics ; Mutation/physiology
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
    Autorzy:
    Niino M; Department of Clinical Research, Hokkaido Medical Center, Yamanote 5jo 7chome, Nishi-ku, Sapporo 063-0005, Japan. .
    Mifune N
    Kohriyama T
    Mori M
    Ohashi T
    Kawachi I
    Shimizu Y
    Fukaura H
    Nakashima I
    Kusunoki S
    Miyamoto K
    Yoshida K
    Kanda T
    Nomura K
    Yamamura T
    Yoshii F
    Kira J
    Nakane S
    Yokoyama K
    Matsui M
    Miyazaki Y
    Kikuchi S
    Pokaż więcej
    Źródło:
    BMC neurology [BMC Neurol] 2014 Jan 06; Vol. 14, pp. 3. Date of Electronic Publication: 2014 Jan 06.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Apathy*
    Cognition Disorders/*psychology
    Depression/*psychology
    Fatigue/*psychology
    Multiple Sclerosis/*psychology
    Adolescent ; Adult ; Aged ; Cognition Disorders/diagnosis ; Cognition Disorders/epidemiology ; Depression/diagnosis ; Depression/epidemiology ; Fatigue/diagnosis ; Fatigue/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/epidemiology ; Neuropsychological Tests ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders.
    Autorzy:
    Watanabe M; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
    Kondo T; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan; Department of Community Network and Collaborative Medicine, Kyoto University Hospital, 54 Kawaharacho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: .
    Murakata K; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
    Kageyama T; Department of Neurology, Tenri Hospital, 200 Mishimacho, Tenri, Nara 632-8552, Japan. Electronic address: .
    Shibata Y; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
    Takahashi T; Department of Neurology, Tohoku University School of Medicine, 1-1 Seiryomachi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. Electronic address: .
    Nomura K; Department of Neurology, Saitama Medical Center, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
    Matsumoto S; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
    Pokaż więcej
    Źródło:
    Journal of neuroimmunology [J Neuroimmunol] 2014 Sep 15; Vol. 274 (1-2), pp. 155-60. Date of Electronic Publication: 2014 Jun 27.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Asians*
    Aquaporin 4/*immunology
    Autoantigens/*immunology
    Membrane Proteins/*immunology
    Multiple Sclerosis/*immunology
    Nerve Tissue Proteins/*immunology
    Neuromyelitis Optica/*immunology
    Adult ; Aged ; Autoantibodies/immunology ; Encephalitis/ethnology ; Encephalitis/immunology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/ethnology ; Neuromyelitis Optica/ethnology ; Receptors, N-Methyl-D-Aspartate/immunology
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    The 36(th) Annual Meeting of the Japanese Society for Apheresis.
    Autorzy:
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama, Japan. .
    Pokaż więcej
    Źródło:
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2016 Aug; Vol. 20 (4), pp. 337-8.
    Typ publikacji:
    Editorial
    MeSH Terms:
    Blood Component Removal*
    Societies, Medical*
    Humans ; Japan
    Opinia redakcyjna
    Szczegóły
    Tytuł:
    Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study.
    Autorzy:
    Yakabi K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Yamaguchi N; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Ono S; Department of Gastroenterology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
    Yoshida N; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Hosomi E; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Hayashi K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Ochiai M; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Maezawa K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Pokaż więcej
    Źródło:
    Current therapeutic research, clinical and experimental [Curr Ther Res Clin Exp] 2017 Jul 31; Vol. 87, pp. 1-8. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Immunoadsorption in neurological disorders.
    Autorzy:
    Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
    Pokaż więcej
    Źródło:
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2017 Oct; Vol. 56 (5), pp. 671-676. Date of Electronic Publication: 2017 Aug 26.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Immunosorbent Techniques*
    Autoantibodies/*blood
    Nervous System Diseases/*therapy
    Humans ; Nervous System Diseases/immunology ; Plasma Exchange
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    A clinical predictive score for postoperative myasthenic crisis.
    Autorzy:
    Kanai T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Sato Y; Department of Global Clinical Research, Graduate School of Medicine, Chiba University, Chiba.
    Suzuki S; Department of Neurology, Keio University School of Medicine, Tokyo.
    Kawaguchi N; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Himuro K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Oda F; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Ozawa Y; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo.
    Suzuki N; Department of Neurology, Keio University School of Medicine, Tokyo.
    Takahashi YK; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
    Ishibashi S; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
    Yokota T; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
    Ogawa T; Department of Neurology, Juntendo University School of Medicine, Tokyo.
    Yokoyama K; Department of Neurology, Juntendo University School of Medicine, Tokyo.
    Hattori N; Department of Neurology, Juntendo University School of Medicine, Tokyo.
    Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
    Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
    Kaneko J; Department of Neurology, Kitasato University School of Medicine, Kanagawa.
    Nishiyama K; Department of Neurology, Kitasato University School of Medicine, Kanagawa.
    Yoshino I; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
    Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
    Pokaż więcej
    Źródło:
    Annals of neurology [Ann Neurol] 2017 Nov; Vol. 82 (5), pp. 841-849. Date of Electronic Publication: 2017 Nov 10.
    Typ publikacji:
    Journal Article; Multicenter Study; Validation Study
    MeSH Terms:
    Myasthenia Gravis/*diagnosis
    Postoperative Complications/*diagnosis
    Female ; Humans ; Male ; Middle Aged ; Myasthenia Gravis/surgery ; Retrospective Studies ; Risk Factors ; Thymectomy/adverse effects
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
    Autorzy:
    Yamagishi Y; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
    Suzuki H; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
    Sonoo M; Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan.
    Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Yokota T; Department of Neurology, Tokyo Medical and Dental University, Faculty of Medicine, Tokyo, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Faculty of Medicine, Kawagoe, Japan.
    Chiba A; Department of Neurology, Kyorin University, Faculty of Medicine, Mitaka, Japan.
    Kaji R; Department of Neurology, Tokushima University, Faculty of Medicine, Tokushima, Japan.
    Kanda T; Department of Neurology, Yamaguchi University, Faculty of Medicine, Ube, Japan.
    Kaida K; Department of Neurology, National Defense Medical College, Tokorozawa, Japan.
    Ikeda SI; Department of Neurology, Shinshu University, Faculty of Medicine, Matsumoto, Japan.
    Mutoh T; Department of Neurology, Fujita Health University School of Medicine, Faculty of Medicine, Toyoake, Japan.
    Yamasaki R; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
    Takashima H; Department of Neurology, Kagoshima University, Faculty of Medicine, Kagoshima, Japan.
    Matsui M; Department of Neurology, Kanazawa Medical University, Kahoku, Japan.
    Nishiyama K; Department of Neurology, Kitazato University, Faculty of Medicine, Sagamihara, Japan.
    Sobue G; Department of Neurology, Nagoya University, Graduate School of Medicine, Nagoya, Japan.
    Kusunoki S; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
    Pokaż więcej
    Źródło:
    Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2017 Dec; Vol. 22 (4), pp. 433-439. Date of Electronic Publication: 2017 Sep 11.
    Typ publikacji:
    Journal Article; Multicenter Study
    MeSH Terms:
    Mobility Limitation*
    Outcome Assessment, Health Care*
    Respiration, Artificial*
    Severity of Illness Index*
    Guillain-Barre Syndrome/*diagnosis
    Immunoglobulin G/*blood
    Adult ; Female ; Follow-Up Studies ; Guillain-Barre Syndrome/blood ; Guillain-Barre Syndrome/physiopathology ; Guillain-Barre Syndrome/therapy ; Humans ; Japan ; Male ; Middle Aged ; Patient Admission ; Prognosis ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation.
    Autorzy:
    Oji S; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan. Electronic address: .
    Tomohisa D; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Hara W; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Tajima T; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Suzuki M; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Saito A; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Yoshida N; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Nomura K; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
    Pokaż więcej
    Źródło:
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2018 Jun; Vol. 27 (6), pp. 1624-1631. Date of Electronic Publication: 2018 Feb 07.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Mean Platelet Volume*
    Platelet Activation*
    Brain Ischemia/*blood
    Stroke/*blood
    Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Brain Ischemia/diagnosis ; Brain Ischemia/physiopathology ; Brain Ischemia/therapy ; Disability Evaluation ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; ROC Curve ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/physiopathology ; Stroke/therapy ; Time Factors
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases.
    Autorzy:
    Sato S; Department of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan.; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
    Teshima S; Department of Pathology, Shonan Kamakura General Hospital, Kamakura, Japan.
    Nakamura N; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
    Ohtake T; Department of Nephrology, Immunology, and Vascular Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.
    Kikuchi J; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Kishi H; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.; Department of Pathology, Doai Memorial Hospital, Tokyo, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Kurose N; Department of Pathology, Kanazawa Medical University, Kanazawa, Japan.
    Masaki Y; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan.
    Tamaru JI; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Pokaż więcej
    Źródło:
    Pathology international [Pathol Int] 2019 Feb; Vol. 69 (2), pp. 97-103. Date of Electronic Publication: 2019 Jan 23.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Lymphoma, Large B-Cell, Diffuse/*pathology
    Vascular Neoplasms/*pathology
    Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplastic Cells, Circulating/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement.
    Autorzy:
    Sugimoto K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, Dongzhimen Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
    Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: .
    Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
    Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Kaneko K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Miyagi National Hospital, Miyagi, Japan.
    Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Takahashi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Japan.
    Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Uchida T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Hiwasa T; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Pokaż więcej
    Źródło:
    Journal of neuroimmunology [J Neuroimmunol] 2019 Nov 15; Vol. 336, pp. 577021. Date of Electronic Publication: 2019 Aug 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Judgment*
    Autoantibodies/*blood
    Flow Cytometry/*standards
    Myelin-Oligodendrocyte Glycoprotein/*blood
    Adult ; Female ; Flow Cytometry/methods ; HEK293 Cells ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Multiple Sclerosis/diagnosis ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/diagnosis ; Reproducibility of Results
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody.
    Autorzy:
    Kojima M; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
    Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
    Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
    Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
    Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
    Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
    Pokaż więcej
    Źródło:
    Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Dec 26; Vol. 39, pp. 101907. Date of Electronic Publication: 2019 Dec 26.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
    Autorzy:
    Tahara M; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan. Electronic address: .
    Oeda T; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
    Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
    Kiriyama T; Department of Neurology, Nara Medical University School of Medicine, Nara, Japan.
    Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
    Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
    Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
    Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
    Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
    Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
    Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
    Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
    Umemura A; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
    Yamamoto K; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
    Sawada H; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
    Pokaż więcej
    Źródło:
    The Lancet. Neurology [Lancet Neurol] 2020 Apr; Vol. 19 (4), pp. 298-306. Date of Electronic Publication: 2020 Mar 18.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Aquaporin 4/*genetics
    Immunologic Factors/*therapeutic use
    Neuromyelitis Optica/*drug therapy
    Rituximab/*therapeutic use
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Disability Evaluation ; Double-Blind Method ; Drug Therapy, Combination ; Evoked Potentials, Visual ; Female ; Humans ; Immunologic Factors/adverse effects ; Infusions, Intravenous ; Japan ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/genetics ; Prednisolone/therapeutic use ; Recurrence ; Rituximab/adverse effects ; Steroids/therapeutic use ; Treatment Outcome ; White Matter/diagnostic imaging ; Young Adult
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Autorzy:
    Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan. Electronic address: .
    Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
    Pokaż więcej
    Źródło:
    Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jun; Vol. 41, pp. 102005. Date of Electronic Publication: 2020 Feb 12.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    B-Lymphocyte Subsets*
    Demyelinating Autoimmune Diseases, CNS*/blood
    Demyelinating Autoimmune Diseases, CNS*/cerebrospinal fluid
    Demyelinating Autoimmune Diseases, CNS*/immunology
    Demyelinating Autoimmune Diseases, CNS*/physiopathology
    Optic Neuritis*/blood
    Optic Neuritis*/cerebrospinal fluid
    Optic Neuritis*/immunology
    Optic Neuritis*/physiopathology
    T-Lymphocyte Subsets*
    Aquaporin 4/*immunology
    Blood-Brain Barrier/*physiopathology
    Myelin-Oligodendrocyte Glycoprotein/*immunology
    Adult ; Female ; Humans ; Male ; Middle Aged ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/cerebrospinal fluid ; Neuromyelitis Optica/immunology ; Neuromyelitis Optica/physiopathology
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
    Autorzy:
    Abe T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Matsuo H; The Japanese Society for Apheresis Guidelines Preparation Committee.; Former President, The Japanese Society for Apheresis.
    Abe R; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Abe S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Asada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ashida A; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Baba A; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Eguchi K; The Japanese Society for Apheresis Guidelines Working Group.
    Eguchi Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Endo Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Fujimori Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Furuichi K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Furukawa Y; The Japanese Society for Apheresis Guidelines Working Group.
    Furuya M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Furuya T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hanafusa N; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hara W; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Harada-Shiba M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hasegawa M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hattori N; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hattori M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hidaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hidaka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Hirayama C; The Japanese Society for Apheresis Guidelines Working Group.
    Ikeda S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Imamura H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Inoue K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ito T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Iwamoto H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Izaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Kagitani M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Kaneko S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Kaneko N; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Kanekura T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Kitagawa K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Kusaoi M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Lin Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Maeda T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Makino H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Makino S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Matsuda K; The Japanese Society for Apheresis Guidelines Working Group.
    Matsugane T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Minematsu Y; The Japanese Society for Apheresis Guidelines Working Group.
    Mineshima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Miura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Miyamoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Moriguchi T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Murata M; The Japanese Society for Apheresis Guidelines Working Group.
    Naganuma M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Nakae H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Narukawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Nohara A; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Nomura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ochi H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ohkubo A; The Japanese Society for Apheresis Guidelines Working Group.
    Ohtake T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Okada K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Okado T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Okuyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Omokawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Oji S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Sakai N; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Sakamoto Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Sasaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Sato M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Seishima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Shiga H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Shimohata H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Sugawara N; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Sugimoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Suzuki Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Suzuki M; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Tajima T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Takikawa Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Tanaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Taniguchi K; The Japanese Society for Apheresis Guidelines Working Group.
    Tsuchida S; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Tsukamoto T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Tsushima K; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Ueda Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Wada T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Yamaka T; The Japanese Society for Apheresis Guidelines Working Group.
    Yamamoto K; The Japanese Society for Apheresis Guidelines Working Group.
    Yokoyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Yoshida N; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Yoshioka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
    Yamaji K; The Japanese Society for Apheresis Guidelines Preparation Committee.; President, The Japanese Society for Apheresis.
    Pokaż więcej
    Źródło:
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2021 Dec; Vol. 25 (6), pp. 728-876.
    Typ publikacji:
    Journal Article; Practice Guideline
    MeSH Terms:
    Blood Component Removal/*methods
    Blood Component Removal/*standards
    Humans ; Japan ; Societies, Medical
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial I-MIBG turnover can identify Lewy body disease.
    Autorzy:
    Kumakura Y; Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center (SMC), Saitama Medical University (SMU), 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. .
    Shimizu Y; Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center (SMC), Saitama Medical University (SMU), 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
    Hariu M; Department of Radiation Oncology, SMC, SMU, Kawagoe, Japan.
    Ichikawa KI; Radiology Center, SMC, SMU, Kawagoe, Japan.
    Yoshida N; Department of Neurology, SMC, SMU, Kawagoe, Japan.
    Suzuki M; Department of Neurology, SMC, SMU, Kawagoe, Japan.
    Oji S; Department of Neurology, SMC, SMU, Kawagoe, Japan.
    Narukawa S; Department of Neurology, SMC, SMU, Kawagoe, Japan.
    Yoshimasu H; Department of Psychiatry, SMC, SMU, Kawagoe, Japan.
    Nomura K; Department of Neurology, SMC, SMU, Kawagoe, Japan.
    Pokaż więcej
    Źródło:
    EJNMMI research [EJNMMI Res] 2021 Dec 14; Vol. 11 (1), pp. 122. Date of Electronic Publication: 2021 Dec 14.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Utility of phrenic nerve conduction studies for identification of patients with neuromuscular diseases requiring invasive mechanical ventilation.
    Autorzy:
    Narukawa S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Ishizuka K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Sugimoto K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
    Pokaż więcej
    Źródło:
    Muscle & nerve [Muscle Nerve] 2022 Feb; Vol. 65 (2), pp. 211-216. Date of Electronic Publication: 2021 Nov 09.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Guillain-Barre Syndrome*/therapy
    Polyradiculoneuropathy, Chronic Inflammatory Demyelinating*
    Humans ; Neural Conduction/physiology ; Neurologic Examination ; Respiration, Artificial
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study.
    Autorzy:
    Hatano T; Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, Japan. .
    Kano O; Department of Neurology, Faculty of Medicine, Toho University, 6-11-1 Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
    Sengoku R; Department of Neurology, Jikei University Daisan Hospital, 4-11-1 Izumihoncho, Komae, Tokyo, 201-0003, Japan.
    Yoritaka A; Department of Neurology, Juntendo University Koshigaya Hospital, 560 Fukuroyama, Koshigaya-shi, Saitama, 343-0032, Japan.
    Suzuki K; Department of Neurology, Dokkyo Medical University Hospital, 880 Oaza Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
    Nishikawa N; Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, Japan.; Department of Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo, 187-8551, Japan.
    Mukai Y; Department of Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo, 187-8551, Japan.
    Nomura K; Department of Neurology, Saitama Medical Center, Kawagoe-shi, Saitama, 350-8550, Japan.
    Yoshida N; Department of Neurology, Saitama Medical Center, Kawagoe-shi, Saitama, 350-8550, Japan.
    Seki M; Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
    Matsukawa MK; Department of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.
    Terashi H; Department of Neurology, Tokyo Medical University Hospital, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
    Kimura K; Department of Neurology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama-shi, Kanagawa, 232-0024, Japan.
    Tashiro J; Sapporo Parkinson MS Neurological Clinic, Dai 27 Big Sapporo-kita Sky Building 12F, 7-6 Kita-7 jo Nishi-5 chome, Kita-ku, Sapporo-shi, Hokkaido, 060-0807, Japan.
    Hirano S; Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.
    Murakami H; Department of Neurology, The Jikei University Hospital, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, 105-8471, Japan.
    Joki H; Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
    Uchiyama T; Department of Neurology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-ku, Hamamatsu-shi, Shizuoka, 430-8558, Japan.
    Shimura H; Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo, 136-0075, Japan.
    Ogaki K; Department of Neurology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba, 279-0021, Japan.
    Fukae J; Department of Neurology, Juntendo University Nerima Hospital, 3-1-10 Takano-dai, Nerima-ku, Tokyo, 177-8521, Japan.
    Tsuboi Y; Department of Neurology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.
    Takahashi K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Musashidai 2-6-1, Fuchu-shi, Tokyo, 183-0042, Japan.
    Yamamoto T; Department of Neurology, Saitama Medical University Hospital, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
    Yanagisawa N; Medical Technology Innovation Center, Juntendo University and Juntendo Clinical Research and Trial Center, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
    Nagayama H; Department of Neurology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan.
    Pokaż więcej
    Źródło:
    BMC neurology [BMC Neurol] 2022 Mar 03; Vol. 22 (1), pp. 71. Date of Electronic Publication: 2022 Mar 03.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Levodopa*/adverse effects
    Parkinson Disease*/drug therapy
    Adenosine A2 Receptor Antagonists/pharmacology ; Adenosine A2 Receptor Antagonists/therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Antiparkinson Agents/therapeutic use ; Humans ; Middle Aged ; Multicenter Studies as Topic ; Purines/pharmacology ; Purines/therapeutic use ; Randomized Controlled Trials as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.
    Autorzy:
    Tahara M; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan. Electronic address: .
    Oeda T; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
    Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
    Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
    Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
    Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
    Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
    Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
    Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
    Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
    Umemura A; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
    Yamamoto K; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
    Sawada H; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
    Pokaż więcej
    Źródło:
    Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Apr; Vol. 60, pp. 103730. Date of Electronic Publication: 2022 Mar 07.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Neuromyelitis Optica*/chemically induced
    Neuromyelitis Optica*/drug therapy
    Compassionate Use Trials ; Humans ; Immunologic Factors/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Prospective Studies ; Rituximab/adverse effects ; Treatment Outcome
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-20 z 20

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

      Prześlij opinię

      Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

      Formularz